111 Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.5M Buy
15,004
+2,857
+24% +$867K 1.12% 15
2026
Q1
$2.6M Buy
12,147
+3,262
+37% +$729K 0.64% 26
2025
Q4
$1.52M Sell
8,885
-18,476
-68% -$2.87M 0.33% 55
2025
Q3
$3.66M Buy
27,361
+10,533
+63% +$1.12M 0.69% 23
2025
Q2
$1.64M Buy
16,828
+6,244
+59% +$495K 0.28% 81
2025
Q1
$769K Sell
10,584
-12,967
-55% -$1.02M 0.15% 156
2024
Q4
$1.7M Buy
+23,551
New +$1.79M 0.36% 57

Other funds holding LRCX

111 Capital's LRCX Position: Q2 2026 in Review

111 Capital increased its Lam Research (LRCX) stake by 24% in Q2 2026, buying an estimated $867K and bringing the position to 15,004 shares worth $6.5M. The position accounts for 1.12% of the portfolio, ranked #15.

111 Capital first reported a position in LRCX in Q4 2024 and has held it in 7 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • 111 Capital held 15,004 shares of Lam Research worth $6.5M as of Q2 2026.
  • 111 Capital bought 2,857 Lam Research shares in Q2 2026, an estimated $867K.
  • Lam Research made up 1.12% of 111 Capital's portfolio in Q2 2026, its #15 holding.
  • 111 Capital first reported a position in Lam Research in Q4 2024 and has held it in 7 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.